Promising Early Phase 2 Results for BioRestorative Therapies' BRTX-100 Lead to Buy Rating
TipRanksFeb 7 03:46
Roth MKM Reiterates Buy on BioRestorative Therapies, Maintains $15 Price Target
BenzingaAug 14, 2023 21:51
BioRestorative Therapies Analyst Ratings
BenzingaAug 14, 2023 21:50
Analysts' Top Healthcare Picks: Ascendis Pharma (ASND), BioRestorative Therapies (BRTX)
TipRanksJun 28, 2023 23:50
Analysts Offer Insights on Healthcare Companies: AxoGen (AXGN) and BioRestorative Therapies (BRTX)
TipRanksMay 10, 2023 00:16
BioRestorative Therapies (BRTX) Gets a Buy From Maxim Group
TipRanksApr 27, 2023 03:38
Maxim Group Keeps Their Buy Rating on BioRestorative Therapies (BRTX)
TipRanksApr 1, 2023 19:35
Maxim Group Keeps Their Buy Rating on BioRestorative Therapies (BRTX)
TipRanksMar 4, 2023 01:22
No Data
No Data